Detalles de la búsqueda
1.
Direct cost and healthcare resource utilization of patients with migraine before treatment initiation with calcitonin gene-related peptide monoclonal antibodies by the number of prior preventive migraine medication classes.
Curr Med Res Opin
; 38(5): 653-660, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34761723
2.
Budget impact of lasmiditan for the acute treatment of migraine in the United States.
J Manag Care Spec Pharm
; 27(12): 1714-1723, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34818093
3.
Demographic and clinical characteristics of prevention-eligible patients with migraine in the US: a linked national survey and administrative claims database study.
Curr Med Res Opin
; 37(3): 443-457, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33331205
4.
Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database.
J Med Econ
; 23(11): 1356-1364, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32845189
5.
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology.
J Cancer
; 10(16): 3717-3727, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31333789
Resultados
1 -
5
de 5
1
Próxima >
>>